Charles River inks $585M buyout; Roche leads $175M Flatiron round;

@FierceBiotech: The scoop on every new drug approved in 2015. Feature | Follow @FierceBiotech

@JohnCFierce: It's all happening so fast--Alector raises $29M; NextCure launches with $67M; Pfizer leads $15M round for Cortexyme. More | Follow @JohnCFierce

@DamianFierce: Tweeting from HATEFUL 8 intermission & have to say it was jarring when Bruce Dern turned to the camera and said "The 8 of us sure are h8ful." | Follow @DamianFierce

> Charles River Laboratories ($CRL) extended its run of acquisitions with a $585 million buyout of WIL Research, picking up a company the CRO said will expand its global footprint and bolster its manufacturing capabilities. Story

> Flatiron Health has raised $175 million for its cloud-based oncology platform, with Roche ($RHHBY) taking the lead. Release

Medical Device News

@FierceMedDev: KKR, Panasonic form newco Ascensia from Bayer Diabetes buy for $1.1B. Article | Follow @FierceMedDev

@EmilyWFierce: Drug price increases saw 'high water mark' year in 2015: Analysts. FiercePharma story | Follow @EmilyWFierce

@VarunSaxena2: NEA partner outlines challenging med tech VC landscape heading into 2016. Article | Follow @VarunSaxena2

> As NEA buys in, FDA calls for more innovative, affordable and effective hearing aids. Story

> J&J launches consumer health and wellness tech accelerator. Article

> Stealth machine learning startup raises $10M to develop a heart disease detection algorithm. More

Pharma News

@FiercePharma: China's Jiangsu Hansoh plans $3B IPO to tap investor demand. FiercePharmaAsia story | Follow @FiercePharma

@CarlyHFierce: MannKind resolves to find new Afrezza marketing deal after Sanofi bails on partnership. FiercePharmaMarketing story | Follow @CarlyHFierce

> If hospitalized Valeant chief makes an exit, it'll be without a parachute. Article

> Drug price increases saw 'high water mark' year in 2015: Analysts. Report

CRO News

> PPD spins out its in-house biotech as sale rumors swirl. More

> Charles River spends $585M on WIL Research amid a buyout spree. Article

> UCB taps Evotec to pitch in on drug discovery. Story

> Altasciences rebrands its web of CROs in hopes of standing out. Report

Pharma Manufacturing News

> Baxter recalls more of its saline solutions after a bug was found. Report

> PharMEDium recalls blood pressure control drug due to discoloration/degradation. More

> French developer TxCell signs Belgian CMO for manufacturing deal. Story

> GSK Australia plant to begin using blow-fill-seal technology for vaccines. Item

> Hospira recalls magnesium sulfate injectable due to bad barcoding. Article

Pharma Asia News

> China's Simcere seeks return to public market with $1B HKEx IPO. Story

> Chinese New Year alert in Hong Kong after bird flu fatality. News

> Wanda plans $2.3B hospital investment in China. More

> Precision medicine plan in China may be announced in March. Report

> Takeda bets on microbiome targets in GI push with Enterome deal. Article

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

While the biotech IPO market booms, it can look like going public is easy. But the right strategy, syndicate and aftermarket are still important.

Gene therapy pioneer Jim Wilson and the University of Pennsylvania are teaming up with Regeneron to help deliver its COVID antibody intransally.

Forty percent of PK deficiency patients on mitapivat had hemoglobalin responses, compared to 0% in the placebo group.